I’ve mentioned before about how many trial protocols feature copied and pasted elements from previous trials, and how this isn’t necessarily the best way to go about designing a new trial.

Another aspect of this approach is when sponsors are looking for outsourcing partners – essentially using the same basic template each time for selecting their CRO, patient recruitment vendor, lab services provider etc.

And again, I’d suggest this isn’t necessarily the best way to go about things, as it could lead to simply setting yourself up to face the same problems you have previously.

Taking a clean piece of paper for understanding and developing your outsourcing strategy at the start of each new project will give you increased clarity on what it is you actually need for successful trial delivery.

Which save you time and resource in such things as protocol amendments and potentially having to replace some of your outsourcing partners.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...